Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
p38β, also known as MAPK11, is a serine/threonine protein kinase that plays a role in cellular responses to stress and inflammatory stimuli. It's part of the p38 MAPK family and is activated by extracellular signals. Unlike other MAPKs, p38β can spontaneously autoactivate. It participates in cell proliferation, differentiation, glucose/lipid metabolism, secretion, stress response, apoptosis, autophagy, and cell migration. It's highly expressed in endothelial cells but has low expression in leukocytes. Small molecule inhibitors like SB202190 and SB203580 inhibit p38β.
Small molecule inhibitors that inhibit kinase activity
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on p38β Mitogen-Activated Protein Kinase (p38β).